Researchers at Queen Mary University of London (QMUL) have developed a way of assembling organic molecules into complex tubular tissue-like structures without the use of moulds or techniques like 3D printing.
The study, which will appear on Monday 28 September in the journal Nature Chemistry, describes how peptides and proteins can be used to create materials that exhibit dynamic behaviors found in biological tissues like growth, morphogenesis, and healing.
The method uses solutions of peptide and protein molecules that, upon touching each other, self-assemble to form a dynamic tissue at the point at which they meet. As the material assembles itself it can be easily guided to grow into complex shapes.
This discovery could lead to the engineering of tissues like veins, arteries, or even the blood-brain barrier, which would allow scientists to study diseases such as Alzheimer’s with a high level of similarity to the real tissue, which is currently impossible. The technique could also contribute to the creation of better implants, complex tissues, or more effective drug screening methods.
Alvaro Mata, Director of the Institute of Bioengineering at QMUL and lead author of the paper, said: “What is most exciting about this discovery is the possibility for us to use peptides and proteins as building-blocks of materials with the capacity to controllably grow or change shape, solely by self-assembly.
The Latest on: Protein/peptide system
via Google News
The Latest on: Protein/peptide system
- Reportable, Inc.: COVAXX Announces $2.8 Billion in Advance Purchase Commitments to Deliver More than 140 Million Vaccine Doses to Emerging Countrieson November 25, 2020 at 6:52 am
Hauppauge, New York--(Newsfile Corp. - November 25, 2020) - COVAXX, a U.S. company developing a multitope peptide ... of the immune system. UB-612 consists of the Spike protein S1 subunit Receptor ...
- Therapeutic Cancer Vaccine Demonstrates Good Safety and Efficacy in Preclinical Studyon November 23, 2020 at 4:00 pm
A study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) described a potential ...
- First checkpoint inhibitor vaccine shown to be safe, effective in colon cancer animal modelon November 22, 2020 at 4:00 pm
Published in the journal Oncoimmunology, on October 1, 2020, the findings showed that the peptide called PD1-Vaxx ... specifically directing the immune system to target and kill cancer cells." ...
- Therapeutic PD-1 cancer vaccine shown to be safe and effective in animal studyon November 19, 2020 at 4:00 pm
A study has described a potential therapeutic anticancer vaccine that frees suppressed cancer-killing immune cells, enabling them to attack and destroy a tumor.
- Oral Proteins and Peptides Market to reach $8.23 billion at a CAGR of 11.7% by 2028on November 17, 2020 at 4:00 pm
The high prevalence rate of chronic diseases, surge in adoption of these drugs, and rise in awareness about oral protein and peptide therapeutics ... (Central Nervous System Stimulants, Tricyclic ...
- Life Extension® Launches New Hydrolyzed Collagen Supplement: Collagen Peptides for Skin and Joints:on November 17, 2020 at 7:22 am
Beautiful News for Your Skin, Joints and Beyond Life Extension's New Collagen Peptides for Skin and Joints. Learn more at Life Extension offers science-backed vitamins and supplements. Learn more at ...
- Peptide is a key mediator in the regulation of compulsive alcohol drinkingon November 16, 2020 at 8:38 am
have identified that a peptide, pituitary adenylate cyclase-activating mediator of compulsive consumption of alcohol. In addition, they have discovered that this protein acts in an area of the ...
- Beetroot Peptide can Help Treat Alzheimer’s, Hypertension and Diabeteson November 15, 2020 at 3:35 pm
A new peptide (a protein unit) discovered in red beetroot can help in the ... The active chemical in the beetroot plant acts as a defense system and protects the plant against attacks by pests. It ...
- Antimalarials could disrupt SARS-CoV-2’s Nsp1 translation terminationon November 15, 2020 at 2:07 pm
A research team from the Engelhardt Institute of Molecular Biology in Russia have shown that Nsp1 – a non-structured protein present in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...
via Bing News